Cambrian is a distributed development company building therapeutics to lengthen health span.
Business Model:
Revenue: $2M
Employees: 11-50
Address: 228 Park Avenue South
City: New York
State: NY
Zip: 10003
Country: US
Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.
Contact Phone:
+15169623186
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2022 | Oviva Therapeutics | Seed | 11.5M |
4/2021 | Arcellx | Series C | - |
6/2021 | Vita Therapeutics | Series A | 0 |
10/2022 | Vita Therapeutics | Series B | 0 |
10/2020 | Sensei Biotherapeutics | Series A | 0 |
1/2021 | Sensei Biotherapeutics | Series B | 0 |
5/2022 | Oviva Therapeutics | Seed Round | 0 |
6/2021 | Vita Therapeutics | Series A | 0 |
4/2021 | Arcellx | Series C | - |
1/2021 | Sensei Biotherapeutics | Series B | 0 |
10/2020 | Sensei Biotherapeutics | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|